Results 101 to 110 of about 11,617 (148)

Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema: 1-Year Results from the China RHINE Subpopulation. [PDF]

Ophthalmol Ther
Li X, Liu X, Jiang Q, Wu Z, Han M, Chen Q, Idowu OO, Liu R, Liu W, Willis JR, Sun X.   +10 more
europepmc   +1 more source

Lower Rates of Intraocular Inflammation with Aflibercept 8 mg Delivered via Pre-Filled Syringe Versus Vial. [PDF]

Ophthalmol Ther
Hoffmann L, Hatz K.
europepmc   +1 more source

Potential impact of nicorandil on the pharmacodynamics of anti-angiogenic agents. [PDF]

Sci Rep
Pan C, Onda K, Ebina K, Kawakami M, Yokosawa M, Hirano T, Suzuki K.   +6 more
europepmc   +1 more source

Reducing the Carbon Footprint of Neovascular Age-Related Macular Degeneration Therapy: Environmental Impact of Transitioning to Aflibercept 8 mg. [PDF]

J Ophthalmol
Veritti D, Misciagna M, Teatino C, Pontoni C, Blasutig M, Kuftic M, Pece S, Morsanutto A, Pece A, Lanzetta P.   +9 more
europepmc   +1 more source

Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States. [PDF]

Pharmacoecon Open
Baljoon A, Diaby V, Suther S, Dutton M, Ali A, Eljilany I.   +5 more
europepmc   +1 more source

Posterior segment inflammation with venous involvement following a switch to a ranibizumab biosimilar (Ximluci®): a case report. [PDF]

Am J Ophthalmol Case Rep
Conte S, Nassisi M, Mainetti C, Seregni L, Viola F.   +4 more
europepmc   +1 more source

Retinal vein occlusion-related macular edema: An updated review of current evidence and future directions. [PDF]

Indian J Ophthalmol
Temkar S, Rajasekar G, Shah AD, Shaikh N, Deb AK, Basa K.   +5 more
europepmc   +1 more source

Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNE. [PDF]

Ophthalmol Sci
Lim JI, Ambresin A, Avery RL, Chaikitmongkol V, Eter N, Gomi F, Khanani AM, London NJS, Harrell E, Margaron P, Patel S, Souverain A, Yang M, Lai TYY.   +13 more
europepmc   +1 more source

Efficacy and Safety of Anti-vascular Endothelial Growth Factor (VEGF) Agents in Diabetic Macular Edema. [PDF]

Cureus
Krishnan B V, Kauser N, Priya G, Sm M.
europepmc   +1 more source

Morphologic Changes of Macular Choroidal Neovascularization on OCT Angiography Following Faricimab Therapy in Patients With AMD. [PDF]

J Vitreoretin Dis
Loya A, Chen V, Siddiqui T, Rao P, Chang EY.   +4 more
europepmc   +1 more source